SCHEMBL18980224

SCHEMBL18980224

O=c1c(Cl)c(Cl)cnn1Cc1sccc1Cl

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HTT P42858 18/20 0.56
▸ ALDH1A1 P00352 16/20 0.56
▸ RAB9A P51151 14/20 0.56
▸ NPSR1 Q6W5P4 10/20 0.56
▸ SMN1; SMN2 Q16637 7/20 0.56
▸ MITF O75030 7/20 0.56
▸ POLB P06746 5/20 0.56
▸ MEN1 O00255 3/20 0.56
▸ KMT2A Q03164 3/20 0.56
▸ PKM P14618 2/20 0.56
▸ BLM P54132 1/20 0.56
▸ GPR35 Q9HC97 1/20 0.56
▸ MAPT P10636 12/20 0.51
▸ LMNA P02545 9/20 0.51
▸ RECQL P46063 2/20 0.51
▸ CYP1A2 P05177 2/20 0.50
▸ CYP2C19 P33261 2/20 0.50
▸ CYP3A4 P08684 1/20 0.50
▸ NPC1 O15118 10/20 0.46
▸ S1PR4 O95977 5/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18980077 0.78 RAB9A (0.58) HTTALDH1A1RAB9ANPSR1SMN1; SMN2
SCHEMBL1691901 0.74 HTT (0.71) HTTALDH1A1RAB9ANPSR1SMN1; SMN2
SCHEMBL19000706 0.74 HTT (0.77) HTTALDH1A1RAB9ANPSR1SMN1; SMN2
SCHEMBL18980129 0.73 RAB9A (0.69) HTTALDH1A1RAB9ANPSR1SMN1; SMN2
SCHEMBL19000708 0.73 HTT (0.60) HTTALDH1A1RAB9ANPSR1SMN1; SMN2
SCHEMBL15674013 0.73 HTT (0.59) HTTALDH1A1RAB9ANPSR1SMN1; SMN2
SCHEMBL10642561 0.72 RAB9A (1.00) HTTALDH1A1RAB9ANPSR1SMN1; SMN2
SCHEMBL9123380 0.72 HTT (0.72) HTTALDH1A1RAB9ANPSR1SMN1; SMN2
SCHEMBL19000711 0.70 RAB9A (0.68) HTTALDH1A1RAB9ANPSR1SMN1; SMN2
SCHEMBL19011573 0.70 RAB9A (0.60) HTTALDH1A1RAB9ANPSR1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170173008-A1 ANTIMICROBIAL AGENTS AND SCREENING METHODS PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) 2017-06-22 — — US disclosed
US-20170173008-A1 ANTIMICROBIAL AGENTS AND SCREENING METHODS PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) 2017-06-22 — — US disclosed
US-20170173008-A1 ANTIMICROBIAL AGENTS AND SCREENING METHODS PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) 2017-06-22 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170173008-A1 ANTIMICROBIAL AGENTS AND SCREENING METHODS BAK1, DCLRE1B, BLVRB HTT 4458/4885ALDH1A1 4273/4885RAB9A 3085/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback